Trial Profile
Compassionate Use of Dupilumab
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 06 Nov 2023
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Allergic bronchopulmonary aspergillosis; Asthma; Atopic dermatitis; Bullous pemphigoid; Chronic obstructive pulmonary disease; Eosinophilic oesophagitis; Nasal polyps; Prurigo nodularis; Pruritus; Rhinosinusitis; Skin disorders
- Focus Expanded access; Therapeutic Use
- Sponsors Regeneron Pharmaceuticals
- 09 Jun 2021 Status changed from suspended to recruiting.
- 16 Apr 2021 Status changed from recruiting to suspended.
- 05 Mar 2021 New trial record